CLINICAL TRIALS PROFILE FOR ASIMADOLINE

Clinical Trials for Asimadoline

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00244153 ↗	Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis	Unknown status	Charite University, Berlin, Germany	Phase 1/Phase 2	Intraarticular application of opioids versus glucocorticosteroids versus placebo in knee arthritis study goals: assessment of effectiveness and tolerability of locally applied morphine, dexamethasone or placebo in knee arthritis
NCT00443040 ↗	Asimadoline for the Treatment of Post-Operative Ileus	Terminated	RTI Health Solutions	Phase 2	The purpose of this study is to evaluate the safety and efficacy of asimadoline in patients who have undergone a laparoscopic segmental colectomy and determine whether it reduces the time to recovery of bowel function compared to placebo.
NCT00443040 ↗	Asimadoline for the Treatment of Post-Operative Ileus	Terminated	Tioga Pharmaceuticals	Phase 2	The purpose of this study is to evaluate the safety and efficacy of asimadoline in patients who have undergone a laparoscopic segmental colectomy and determine whether it reduces the time to recovery of bowel function compared to placebo.
NCT00454688 ↗	Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome	Completed	RTI Health Solutions	Phase 2	The purpose of this study is to evaluate the safety and efficacy of different doses of asimadoline in the treatment of patients with irritable bowel syndrome.
NCT00454688 ↗	Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome	Completed	Tioga Pharmaceuticals	Phase 2	The purpose of this study is to evaluate the safety and efficacy of different doses of asimadoline in the treatment of patients with irritable bowel syndrome.
NCT00955994 ↗	Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome	Completed	Mayo Clinic	Phase 2	The treatment of acute pain in patients with irritable bowel symptoms is suboptimal. This is a placebo controlled study of the on demand treatment of pain experienced over a 4 week period in patients with irritable bowel syndrome. Patients will record the severity of pain when they take the study medication and two hours later.
NCT01100684 ↗	Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)	Completed	RTI Health Solutions	Phase 3	The purpose of this study is to determine whether asimadoline is safe and effective at treating D-IBS.

Clinical Trial Conditions for Asimadoline

Condition Name

Condition Name
Intervention	Trials
Irritable Bowel Syndrome	2
Atopic Dermatitis	1
Diarrhea Predominant Irritable Bowel Syndrome	1
Healthy	1

Condition MeSH

Condition MeSH
Intervention	Trials
Syndrome	3
Irritable Bowel Syndrome	3
Eczema	1
Rheumatic Diseases	1

Clinical Trial Locations for Asimadoline

Trials by Country

Trials by Country
Location	Trials
United States	91
Germany	1

Trials by US State

Trials by US State
Location	Trials
Missouri	4
Oregon	3
North Carolina	3
New York	3
Minnesota	3

Clinical Trial Progress for Asimadoline

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	4
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	5
Unknown status	1
Terminated	1

Clinical Trial Sponsors for Asimadoline

Sponsor Name

Sponsor Name
Sponsor	Trials
Tioga Pharmaceuticals	5
RTI Health Solutions	3
Charite University, Berlin, Germany	1

Sponsor Type

Sponsor Type
Sponsor	Trials
Other	5
Industry	5